Winton Capital »

Beam Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2023-03-31 $271k 8.8k 30.62

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Select Sector Spdr Tr Communication (XLC)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Technology (XLK)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Union Pacific Corporation (UNP)
Centene Corporation (CNC)
Copart (CPRT)
Sempra Energy (SRE)
Expedia Group Com New (EXPE)
NetApp (NTAP)
Jabil Circuit (JBL)
Constellation Energy (CEG)
Metropcs Communications (TMUS)

View all positions for Winton Capital

Top funds holding Beam Therapeutics

ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
Yiheng Capital
Baillie Gifford & Co
Bellevue Group
Charles Schwab Investment Management
Dimensional Fund Advisors
Casdin Capital
Jpmorgan Chase & Co
Goldman Sachs Group
Bank of New York Mellon
Tang Capital Management

View all funds holding Beam Therapeutics